Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney Transplantation
Open Access
- 1 July 2004
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (7) , 1079-1083
- https://doi.org/10.1111/j.1600-6143.2004.00455.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Basiliximab widens the therapeutic window for AUC-monitored neoral therapy early after kidney transplantationTransplantation Proceedings, 2003
- Mycophenolate Mofetil Dose Reduction and the Risk of Acute Rejection after Renal TransplantationJournal of the American Society of Nephrology, 2003
- Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation1Transplantation, 2003
- Mycophenolate Mofetil for Solid Organ Transplantation: Does the Evidence Support the Need for Clinical Pharmacokinetic Monitoring?Therapeutic Drug Monitoring, 2003
- WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation1Transplantation, 2003
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1Transplantation, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1997
- REDUCTION BY COMBINATION PROPHYLACTIC THERAPY WITH CMV HYPERIMMUNE GLOBULIN AND ACYCLOVIR OF THE RISK OF PRIMARY CMV DISEASE IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1993